Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Santini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuropsychiatric Disease and Treatment|June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 19, 2003
Season of birth and inflammatory response system in schizophreniaA Carlo Altamura, Roberta Bassetti, Luisella Bocchio, et al.
Journal of Affective Disorders|August 29, 2003
Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label studyA C Altamura, Daniele Salvadori, Donato Madaro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2004
Emotional withdrawal, CT abnormalities and drug response in late life depressionA Carlo Altamura, Roberta Bassetti, Annalisa Santini, et al.
Drugs|February 26, 2003
Intramuscular preparations of antipsychotics: uses and relevance in clinical practiceA Cario Altamura, Francesca Sassella, Annalisa Santini, et al.
Science Translational Medicine|April 22, 2026
Functional correction of the untreatable <i>CFTR</i> 1717-1G>A mutation through mRNA- and sgRNA-optimized base editingAlessandro Umbach, Annalisa Santini, Mattijs Bulcaen, et al.
Blood|September 19, 2025
VEXAS anemia is a mosaic erythroblastopeniaFrancois Rodrigues, Giulia Hardouin, Sara El Hoss, et al.
Molecular Therapy. Nucleic Acids|February 24, 2025
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working GroupAlessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuropsychiatric Disease and Treatment|June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 19, 2003
Season of birth and inflammatory response system in schizophreniaA Carlo Altamura, Roberta Bassetti, Luisella Bocchio, et al.
Journal of Affective Disorders|August 29, 2003
Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label studyA C Altamura, Daniele Salvadori, Donato Madaro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2004
Emotional withdrawal, CT abnormalities and drug response in late life depressionA Carlo Altamura, Roberta Bassetti, Annalisa Santini, et al.
Drugs|February 26, 2003
Intramuscular preparations of antipsychotics: uses and relevance in clinical practiceA Cario Altamura, Francesca Sassella, Annalisa Santini, et al.
Science Translational Medicine|April 22, 2026
Functional correction of the untreatable <i>CFTR</i> 1717-1G>A mutation through mRNA- and sgRNA-optimized base editingAlessandro Umbach, Annalisa Santini, Mattijs Bulcaen, et al.
Blood|September 19, 2025
VEXAS anemia is a mosaic erythroblastopeniaFrancois Rodrigues, Giulia Hardouin, Sara El Hoss, et al.
Molecular Therapy. Nucleic Acids|February 24, 2025
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working GroupAlessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Pageof 1